The latest on the shortage of chemotherapy drugs.
Shortages of drugs from Adderall, which is commonly used to treat attention-deficit/hyperactivity disorder (ADHD), to the type-2 diabetes drug Ozempic have impacted patients throughout the U.S. over the past year.
The U.S. Food and Drug Administration (FDA) and drug companies have linked some of the shortages to supply chain issues coupled with increased demand for the drugs.
More than a dozen oncology drugs used to treat cancer are currently in short supply, according to the FDA drug shortages database and the American Cancer Society (ACS). That includes some drugs used in chemotherapy treatments.
Chemotherapy drugs were in the top five drug categories affected by shortages through the end of March 2023, according to data compiled by the University of Utah Drug Information Service.
The ACS attributed the chemotherapy drug shortages to “expanded demand, supply shortages, limited manufacturing capacity and low profit margins for generic therapies,” among other factors.
Some of the drugs impacted by the shortages do not have effective alternatives, the ACS added.
READ MORE: [ Ссылка ]
At 3News, we’re not here to tell you the news, we’re here to share the stories that you say matter most to you. Share your ideas, thoughts, concerns and engage in conversations about the communities in which we all call home.
Follow 3News on Social:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Visit our site: [ Ссылка ]
And be sure to download our app here: [ Ссылка ]
